Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.77 |
| ▸ | CA1 | P00915 | 1/20 | 0.77 |
| ▸ | CA2 | P00918 | 1/20 | 0.77 |
| ▸ | CA7 | P43166 | 1/20 | 0.77 |
| ▸ | CA9 | Q16790 | 1/20 | 0.77 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | TTR | P02766 | 1/20 | 0.66 |
| ▸ | DPP4 | P27487 | 1/20 | 0.66 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | FDPS | P14324 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | FOS | P01100 | 1/20 | 0.51 |
| ▸ | JUN | P05412 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1894062 | 1.00 | CA12 (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13957155 | 1.00 | CA12 (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5059085 | 0.94 | CA12 (0.86) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10939791 | 0.94 | CA12 (0.86) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13957401 | 0.94 | CA12 (0.86) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1260527 | 0.92 | CA12 (0.83) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3143890 | 0.92 | CA12 (0.83) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2075719 | 0.92 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL20857445 | 0.92 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10505915 | 0.92 | CA12 (0.67) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112067718-B | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-109796338-B | Synthetic method of ozagrel intermediate p-bromomethyl cinnamate | 深圳市第二人民医院 | 2022-05-06 | — | — | CN | claimed |
| CN-112067718-A | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2020-12-11 | — | — | CN | claimed |
| EP-1100432-B1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PROD INC (US) | 2007-12-19 | — | — | EP | claimed |
| EP-1100432-A4 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PROD INC (US) | 2003-06-04 | — | — | EP | claimed |
| EP-1100432-A1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PRODUCTS, INC. (US) | 2001-05-23 | — | — | EP | claimed |
| US-6162450-A | Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same | AVON PRODUCTS, INC. (US) | 2000-12-19 | — | — | US | claimed |
| WO-2000006091-A1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PRODUCTS, INC. (US) | 2000-02-10 | — | — | WO | claimed |
| CN-115141098-B | Method for preparing ozagrel intermediate through microchannel reaction | 赤峰经方医药技术开发有限责任公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-112794837-B | Synthesis method of heterochroman compound | 云南大学 | 2023-05-23 | — | — | CN | disclosed |
| CN-116135861-A | Method for preparing boronated carbonyl derivative from alpha, beta-unsaturated carbonyl derivative | 中国科学院大连化学物理研究所 | 2023-05-19 | — | — | CN | disclosed |
| CN-115141098-A | Method for preparing ozagrel intermediate through microchannel reaction | 赤峰经方医药技术开发有限责任公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-112067718-B | Establishment method of muskiness rheumatalgia-relieving plaster volatile component fingerprint, standard fingerprint and application thereof | 重庆希尔安药业有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114436964-A | Continuous preparation method of ozagrel | 赤峰经方医药技术开发有限责任公司 | 2022-05-06 | — | — | CN | disclosed |
| US-5043510-A | Aqueous alkylation process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-08-27 | — | — | US | disclosed |
| US-4335054-A | Process for the preparation of alkenylbenzenecarboxylic acid derivatives and alkenylnaphthalenecarboxylic acid derivatives | CIBA-GEIGY CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| US-4260771-A | VASODILATORS, ANTICOAGULANTS, IMMUNOLOGY | MERCK & CO., INC. (US) | 1981-04-07 | — | — | US | disclosed |
| US-4175203-A | TREATMENT OF RENAL FAILURE AND TRANSPLANT REJECTION VASODILATORS | MERCK & CO., INC. (US) | 1979-11-20 | — | — | US | disclosed |
| US-4150235-A | ANTIBODY INHIBITORS, HYPOTENSIVE AGENTS, DIURETICS, VASODILATOR | MERCK & CO., INC. (US) | 1979-04-17 | — | — | US | disclosed |
| US-4140861-A | RENAL DISFUNCTION, ANTIBODY INHIBITORS | MERCK & CO., INC. (US) | 1979-02-20 | — | — | US | disclosed |